Aurora Financial JournalChemoMetec (CHEMM.CO)
Nasdaq Copenhagen · Financial statements, TTM figures and earnings dates
In fiscal year 2025 (ended June 30, 2025), ChemoMetec reported revenue of DKK 495.6M and net income of DKK 186.4M. Annual financial statements are available for fiscal years 2021 to 2025, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| DKK | FY2025 2025-06-30 | FY2024 2024-06-30 | FY2023 2023-06-30 | FY2022 2022-06-30 | FY2021 2021-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | DKK 495.6M | DKK 407.4M | DKK 442.3M | DKK 427.2M | DKK 281.1M |
| Gross profit | DKK 465.5M | DKK 367.6M | DKK 411.5M | DKK 384.3M | DKK 253.3M |
| Operating income | DKK 236.5M | DKK 169.0M | DKK 230.6M | DKK 202.9M | DKK 116.0M |
| Net income | DKK 186.4M | DKK 136.3M | DKK 178.7M | DKK 159.5M | DKK 88.4M |
| Diluted EPS | DKK 10.71 | DKK 7.83 | DKK 10.27 | DKK 9.16 | DKK 5.08 |
| Cash flow | |||||
| Operating cash flow | DKK 207.4M | DKK 129.0M | DKK 154.1M | DKK 176.9M | DKK 107.9M |
| Capital expenditure | DKK 29.9M | DKK 20.9M | DKK 21.2M | DKK 39.1M | DKK 11.2M |
| Free cash flow | DKK 177.6M | DKK 108.1M | DKK 133.0M | DKK 137.8M | DKK 96.7M |
| Balance sheet | |||||
| Cash and equivalents | DKK 341.8M | DKK 296.1M | DKK 316.6M | DKK 209.0M | DKK 150.1M |
| Total assets | DKK 828.0M | DKK 676.7M | DKK 658.0M | DKK 501.3M | DKK 344.9M |
| Total liabilities | DKK 154.7M | DKK 111.4M | DKK 124.9M | DKK 144.1M | DKK 79.9M |
| Total debt | DKK 1.5M | DKK 1.3M | DKK 1.0M | DKK 1.0M | DKK 592.0K |
| Shareholders' equity | DKK 673.4M | DKK 565.3M | DKK 533.0M | DKK 357.2M | DKK 265.0M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full CHEMM.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open CHEMM.CO financials →